Czech Republic - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Czech Republic Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes increased 2% year on year. With €132.23 Per Capita in 2019, the country was ranked number 23 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Czech Republic is overtaken by Denmark, which was number 22 at €142.9 Per Capita and is followed by Croatia with €131.94 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, a growth of 3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.

Loading...

Date Euros Per Capita
2019 132.23
2018 134.93
2017 128.11
2016 122.51
2015 120.18
Download all data from 2013 to 2019

How does Czech Republic rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
22 #22
Denmark
142.90 2019 -3.2 % -0.3 % View data
23 #23
Czech Republic
132.23 2019 -2.0 % +2.0 % View data
24 #24
Croatia
131.94 2019 -1.4 % +2.2 % View data
Compare all 33 countries

Go Top